Context
The Centre has requested pharma agencies for details of expenditure on advertising in the last year.
About
- The Union government is keeping a close watch at the marketing exercise of pharmaceutical companies amid reviews of those businesses persevering with providing a variety of freebies to medical doctors.
- The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) is being applied to test unethical advertising practices.
- The info sought by the Department of Pharmaceuticals (DoP) should be submitted by 31 July, failing which movement can be taken against them.
Uniform Code for Pharmaceutical Marketing Practices (UCPMP)
- The UCPMP was added in 2024 with an aim to result in transparency and make certain ethical conduct in the advertising and marketing practices of pharmaceutical businesses.
- Prohibition of Inducements: Companies are barred from offering goods, financial blessings, or hospitality to healthcare experts or their households.
- Restrictions on Travel and Hospitality: Providing journey centers or hospitality is unlawful until the healthcare expert is a speaker at a Continuing Medical Education (CME) occasion. Even then, events cannot be held in foreign locations.
- Accountability and Transparency: Pharmaceutical companies need to self-declare adherence to the code and reveal prices associated with conferences, seminars, and workshops.
- Enforcement Mechanism: An Ethics Committee for Pharmaceutical Marketing Practices (ECPMP) is hooked up within each affiliation to cope with violations.
What are Freebies?
- Freebies also called the “Doctors’ Commission” wherein pharma companies deliver out gifts, in coins or kind, to medical professionals to prescribe their brand of drug.
Key concerns related to this dating
- Conflict of Interest: Doctors are expected to make medical decisions primarily based on the interests of patients, and financial or material benefits compromise this objectivity.
- Patient Trust and Confidence: Patients depend on the information and impartial judgment of their medical doctors, and any notion of undue influence from pharmaceutical companies can undermine this trust.
- Economic Impact on Healthcare Costs: If docs are stimulated to prescribe greater high priced medicines because of relationships with pharmaceutical companies, it contributes to high healthcare costs.
- Professional Ethics and Integrity: Medical professionals are expected to adhere to ethical requirements that prioritize affected person welfare.
Recommendations
- A 5-member committee headed by Vinod K. Paul (2023) to the Union government upon reviewing the UCPMP made few hints on freebies to Doctors via Pharma.
- The rate of branded presents to docs need to not exceed ₹1,000 per item.
- Prohibition on the continuous scientific training (CME) workshops for docs in foreign places.
- The cash received by medical practitioners from pharmaceutical companies to conduct research must be taxable.
- In the case of free drug samples, tax has to be deducted at source for the corporation under the Income Tax (I-T) Act if their cost exceeds ₹20,000 per year.
Conclusion
- The nexus among pharmaceutical companies and doctors in India poses considerable moral challenges, leading to compromised patient care and inflated healthcare costs.
- Most of the guidelines are actually partly pondered in the UCPMP 2024, and ongoing reforms, even though specialists preserve to demand in addition prison enforcement and independent oversight mechanisms.
- Strengthening regulation, ensuring transparency in medical-industry relationships, and prioritizing affected person welfare over profit are essential steps in the direction of restoring integrity in healthcare delivery.
Source: The News on AIR
Mains PYQ
Q. How is the Government of India protecting traditional knowledge of medicine from patenting by pharmaceutical companies? (2019)
.png)
